Nektar Therapeutics | NKTR - Interest Income


Nektar Therapeutics reported $-0.18 in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
Agios Pharmaceuticals USD 13.37M 1.14M Sep/2025
ALKERMES USD 11.94M 853K Sep/2025
Baxter International USD 10M 4M Sep/2025
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Biogen USD 31.6M 700K Sep/2025
Cara Therapeutics USD 347K 74K Mar/2025
Dr.Reddys Laboratories INR 796M 116M Dec/2025
Eisai JPY 3.11B 783M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Exelixis USD 15.92M 867K Sep/2025
Gilead Sciences USD 88M 15M Sep/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Incyte USD 30.75M 3.97M Dec/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Ironwood Pharmaceuticals USD 778K 374K Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.53M 114K Sep/2025
Merck USD 96M 27M Sep/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pfizer USD 0.62 156M Sep/2025
Sarepta Therapeutics USD 8.38M 1.24M Sep/2025
Takeda JPY 87.87B 43.48B Dec/2025
Xencor USD 6.54M 710K Sep/2025